Skip to content
healthcare.dev

Droxidopa

NDC 50228-430, droxidopa, capsule, from ScieGen Pharmaceuticals Inc.

Product NDC
50228-430
Status
Listed
Labeler
ScieGen Pharmaceuticals Inc
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA214017
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/50228-430 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DROXIDOPA200 mg/1

Pharmacologic classes

Catecholamines [CS]; Increased Blood Pressure [PE]

Package NDCNDC-11Package
50228-430-10502280430101000 CAPSULE in 1 BOTTLE (50228-430-10)
50228-430-305022804303030 CAPSULE in 1 BOTTLE (50228-430-30)
50228-430-905022804309090 CAPSULE in 1 BOTTLE (50228-430-90)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/10b02d98-ebb8-4152-bd56-3402417fbf79
  • NADAC price for package 50228043090

    GET /v1/drugs/nadac/50228043090

Use it

Look up 50228-430 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/50228-430 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 50228-430. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.